Trypanocidal activity of the proteasome inhibitor and anti-cancer drug bortezomib
<p>Abstract</p> <p>The proteasome inhibitor and anti-cancer drug bortezomib was tested for <it>in vitro </it>activity against bloodstream forms of <it>Trypanosoma brucei</it>. The concentrations of bortezomib required to reduce the growth rate by 50% and to...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2009-07-01
|
| Series: | Parasites & Vectors |
| Online Access: | http://www.parasitesandvectors.com/content/2/1/29 |